← Back to Clinical Trials
Recruiting NCT07265882

NCT07265882 Bed Side Assessment in Patients With Acute Respiratory Failure Under Invasive Mechanical Ventilation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07265882
Status Recruiting
Phase
Sponsor Fondazione IRCCS Policlinico San Matteo di Pavia
Condition Acute Respiratory Failure (ARF)
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2022-11-14
Primary Completion 2026-07-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 90 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2022-11-14 with a primary completion date of 2026-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to learn about the respiratory mechanics in patients undergoing mechanical ventilation. The investigators can achieve this through the offline analysis of data provided by the ventilator. Within the field of respiratory mechanics, the study focuses particularly on the quantification of lung instability. What does lung instability mean? By this definition, the investigators refer to the part of lung tissue that opens during inspiration and then collapses during the subsequent expiration. The more diseased the lung (for example, in the case of viral pneumonia), the greater the quantity of this tissue. How is lung instability measured? In the context of the study analysis, lung instability is measured through the analysis of the low flow pressure-volume loop during ventilation. This graph illustrates how the volume of air in the lungs varies in response to the pressures applied by the ventilator during slow inflation and deflation phases. This maneuver is considered quick and safe and has been an integral part of our clinical practice for several years. Through this maneuver, investigators can examine the range of pressures provided by the ventilator during tidal ventilation. To assess lung instability, hysteresis is analyzed, which represents a distinctive characteristic of the pressure-volume loop. Greater hysteresis indicates a higher degree of lung instability. During the study, investigators will record not only hysteresis but also classical respiratory mechanics parameters (for example, elastance of the respiratory system, i.e., how stiff the lung is), parameters regarding gas exchange (blood oxygen and carbon dioxide levels), biometric data (for example, height and weight), and imaging (CT scans, lung ultrasound, and electrical impedance tomography) to relate them to the degree of lung instability.

Eligibility Criteria

Inclusion Criteria: * patients undergoing passive mechanical ventilation Exclusion Criteria: * hemodynamic instability * confirmed intracranial hypertension

Contact & Investigator

Central Contact

Marco Pozzi, MD

✉ ma.pozzi@smatteo.pv.it

📞 +39 0382503711

Frequently Asked Questions

Who can join the NCT07265882 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Acute Respiratory Failure (ARF). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07265882 currently recruiting?

Yes, NCT07265882 is actively recruiting participants. Contact the research team at ma.pozzi@smatteo.pv.it for enrollment information.

Where is the NCT07265882 trial being conducted?

This trial is being conducted at Pavia, Italy.

Who is sponsoring the NCT07265882 clinical trial?

NCT07265882 is sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology